TY - JOUR
T1 - Single-chamber cardiac pacing with activity-initiated chronotropic response
T2 - Evaluation by cardiopulmonary exercise testing
AU - Benditt, David G
AU - Mianulli, M.
AU - Fetter, J.
AU - Benson, D. W.
AU - Dunnigan, Ann
AU - Molina, J Ernesto
AU - Gornick, C. C.
AU - Almquist, A.
PY - 1987
Y1 - 1987
N2 - In this study, sequential cardiopulmonary exercise testing was used to assess the physiologic benefits of a single-chamber ventricular pacing system that utilizes a piezoceramic sensor to adjust heart rate by detecting 'physical activity'. An initial exercise test was conducted with the pacemaker programmed (based on a randomization table) to either the fixed rate (VVI, 70 beats/min) or rate-variable (VVI-Act) mode, and the results were compared with those obtained during a second exercise test in which the pacemaker was programmed to the alternate pacing mode. A 1.5 to 2 hr rest period was permitted between exercise tests, each of which consisted of a symptom-limited constant speed (3.0 mph) Balke protocol with 2 min stages commencing at 0.0% grade with increments of 2.5% at end of each stage. Compared with findings during fixed-rate VVI pacing, VVI-Act pacing was associated with (1) greater exercise-induced positive chronotropic response (mean maximum heart rate VVI-Act 128 ± 15.3 beats/min vs VVI 90 ± 28.4 beats/min; p<.01), (2) prolongation of exercise duration (VVI-Act 10.2 ± 3.8 min vs VVI 7.7 ± 2.5 min; p<.01), (3) increased peak oxygen consumption (VVI-Act 1617 ± 656 ml O2/min vs VVI 1325 ± 451 ml O2/min; p<.01), and (4) onset of anaerobic threshold at a higher oxygen consumption (VVI-Act 1208 ± 343 ml O2/min vs VVI 1064 ± 377 ml O2/min; p<.01). Additionally, of 44 comparable exercise stages tested in the two pacing modes, perceived exertion (assessed by a numerical grading system) was lower in 38 of 44 instances during VVI-Act compared with VVI pacing. Thus provision of chronotropic response during exercise by single chamber rate-variable ventricular pacing substantially improved exercise tolerance and therefore may be of benefit for patients with bradycardia-related symptoms in whom associated sinoatrial disease or difficulty establishing or maintaining atrial sensing preclude optimum function of conventional atrial-tracking pacing systems.
AB - In this study, sequential cardiopulmonary exercise testing was used to assess the physiologic benefits of a single-chamber ventricular pacing system that utilizes a piezoceramic sensor to adjust heart rate by detecting 'physical activity'. An initial exercise test was conducted with the pacemaker programmed (based on a randomization table) to either the fixed rate (VVI, 70 beats/min) or rate-variable (VVI-Act) mode, and the results were compared with those obtained during a second exercise test in which the pacemaker was programmed to the alternate pacing mode. A 1.5 to 2 hr rest period was permitted between exercise tests, each of which consisted of a symptom-limited constant speed (3.0 mph) Balke protocol with 2 min stages commencing at 0.0% grade with increments of 2.5% at end of each stage. Compared with findings during fixed-rate VVI pacing, VVI-Act pacing was associated with (1) greater exercise-induced positive chronotropic response (mean maximum heart rate VVI-Act 128 ± 15.3 beats/min vs VVI 90 ± 28.4 beats/min; p<.01), (2) prolongation of exercise duration (VVI-Act 10.2 ± 3.8 min vs VVI 7.7 ± 2.5 min; p<.01), (3) increased peak oxygen consumption (VVI-Act 1617 ± 656 ml O2/min vs VVI 1325 ± 451 ml O2/min; p<.01), and (4) onset of anaerobic threshold at a higher oxygen consumption (VVI-Act 1208 ± 343 ml O2/min vs VVI 1064 ± 377 ml O2/min; p<.01). Additionally, of 44 comparable exercise stages tested in the two pacing modes, perceived exertion (assessed by a numerical grading system) was lower in 38 of 44 instances during VVI-Act compared with VVI pacing. Thus provision of chronotropic response during exercise by single chamber rate-variable ventricular pacing substantially improved exercise tolerance and therefore may be of benefit for patients with bradycardia-related symptoms in whom associated sinoatrial disease or difficulty establishing or maintaining atrial sensing preclude optimum function of conventional atrial-tracking pacing systems.
UR - http://www.scopus.com/inward/record.url?scp=0023088434&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023088434&partnerID=8YFLogxK
U2 - 10.1161/01.CIR.75.1.184
DO - 10.1161/01.CIR.75.1.184
M3 - Article
C2 - 3791604
AN - SCOPUS:0023088434
SN - 0009-7322
VL - 75
SP - 184
EP - 191
JO - Circulation
JF - Circulation
IS - 1
ER -